Table of contents
Integrate once, interoperate with all suppliers to achieve item-level traceability compliance and improve operational efficiency.
DSCSA 2023 introduces significant regulatory compliance challenges and new operational complexities for drug manufacturers. To meet these requirements, manufacturers will need to configure hundreds or thousands of custom integrations to their key trading partners.
TraceLink DSCSA 2023 Compliance for Drug Manufacturers can help. Download this solution brief to see how our network-based approach enables manufacturers to integrate once, interoperate with everyone for quick and secure data sharing and achieve DSCSA compliance. Benefits include:
- Send EPCIS data seamlessly, with no-cost onboarding for customers or trading partners.
- Powerful scalability to keep up with the increased number of transactions processed.
- Disruption-free upgrades with new functionality added in response to evolving regulations.
Download the solution brief today and see how you can achieve DSCSA compliance while improving operational efficiency.
